About Geoffrey Dow
Geoffrey Dow is a president and CEO, director at 60 Degrees Pharmaceuticals.
Geoffrey Dow reports to the SEC as a director, officer or major shareholder of 1 public company.
Geoffrey Dow first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Geoffrey Dow in the role, so the role may have started earlier or lasted longer.